Savara Inc Repayments of Long-Term Debt
Savara Inc (SVRA) reported Repayments of Long-Term Debt of $27.23 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2026-08-11
- Savara Inc repayments of long-term debt for the quarter ending 2025-12-31 was $0.00.
- Savara Inc repayments of long-term debt for the quarter ending 2025-09-30 was -$1.00K.
- Savara Inc repayments of long-term debt for the quarter ending 2025-06-30 was $0.00.
- Savara Inc repayments of long-term debt for the quarter ending 2025-03-31 was $27.23M.
- Savara Inc repayments of long-term debt for fiscal 2025 was $27.23M.
- Savara Inc repayments of long-term debt for fiscal 2022 was $26.35M.
- Savara Inc repayments of long-term debt for fiscal 2020 was $514.00K.
- Savara Inc repayments of long-term debt for fiscal 2017 was $3.57M.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month | Repayments of Long-term Debt 181 month | Repayments of Long-term Debt 184 month | Repayments of Long-term Debt 187 month | Repayments of Long-term Debt 190 month | Repayments of Long-term Debt 193 month | Repayments of Long-term Debt 196 month | Repayments of Long-term Debt 199 month | Repayments of Long-term Debt 202 month | Repayments of Long-term Debt 205 month | Repayments of Long-term Debt 208 month | Repayments of Long-term Debt 211 month | Repayments of Long-term Debt 214 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$1.00K derived: sum of 2 quarters · filed 2026-03-13 | -$1.00K derived: sum of 3 quarters · filed 2026-08-11 | $27.23M 10-K · filed 2026-03-13 | ||||||||||||
| 2025-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$1.00K derived: sum of 2 quarters · filed 2026-08-11 | $27.23M 10-Q · filed 2025-11-12 | |||||||||||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $27.23M 10-Q · filed 2026-08-11 | ||||||||||||||
| 2025-03-31 | $27.23M 10-Q · filed 2026-05-12 | |||||||||||||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $0.00 derived: sum of 2 quarters · filed 2024-03-07 | $26.35M 10-K · filed 2024-03-07 | |||||||||||||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $26.35M 10-Q · filed 2023-11-09 | ||||||||||||||
| 2022-06-30 | $26.35M 10-Q · filed 2023-08-10 | |||||||||||||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $514.00K 10-K · filed 2022-03-30 | ||||||||||||||
| 2020-09-30 | $514.00K 10-Q · filed 2021-11-12 | |||||||||||||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $0.00 derived: sum of 2 quarters · filed 2018-11-07 | $3.57M 10-K · filed 2018-03-14 | |||||||||||||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $3.57M 10-Q · filed 2018-11-07 | ||||||||||||||
| 2017-06-30 | $3.57M 10-Q · filed 2018-08-09 | |||||||||||||||
| 2014-03-31 | $605.91K 10-Q · filed 2014-05-05 | |||||||||||||||
| 2013-12-31 | $605.91K 10-K · filed 2014-03-26 | |||||||||||||||
| 2013-09-30 | $605.91K 10-Q · filed 2013-11-04 | |||||||||||||||
| 2013-06-30 | $605.91K 10-Q · filed 2013-08-05 | |||||||||||||||
| 2013-03-31 | $605.91K 10-Q · filed 2013-05-15 | |||||||||||||||
| 2012-12-31 | $605.91K 10-K · filed 2013-03-19 | |||||||||||||||
| 2012-09-30 | $605.91K 10-Q · filed 2012-11-05 | |||||||||||||||
| 2012-06-30 | $605.91K 10-Q · filed 2012-08-06 | |||||||||||||||
| 2012-03-31 | $605.91K 10-Q · filed 2012-05-07 | |||||||||||||||
| 2011-12-31 | $605.91K 10-K · filed 2012-03-08 | |||||||||||||||
| 2011-09-30 | $605.91K 10-Q · filed 2011-11-08 | |||||||||||||||
| 2011-06-30 | $605.91K 10-Q · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |